Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/53520
Título: Ceramide mediates tumor necrosis factor effects on P450-aromatase activity in cultured granulosa cells
Autores/as: Santana Delgado, María Del Pino 
Llanes, Luz
Gonzalez, Juan
Ruiz de Galarreta, Carlos
Fanjul Rodríguez, Luisa Fernanda 
Hernández González, Inmaculada Servanda 
Quintana, José
Estévez Rosas, Francisco Jesús 
Clasificación UNESCO: 32 Ciencias médicas
320502 Endocrinología
Palabras clave: Factor-Alpha
Sphingomyelin Turnover
Molecular-Cloning
Differentiation
Steroidogenesis, et al.
Fecha de publicación: 1995
Publicación seriada: Endocrinology (Philadelphia) 
Resumen: In [3H]serine-labelled granulosa cells treatment with TNF alpha (10 ng/ml) resulted in a transient decrease in cellular [3H]sphingomyelin and generation of [3H]ceramide that remained elevated 60 min later. In cells labelled with [methyl-14C]choline, TNF alpha induced a similar reduction in [14C]sphingomyelin content that was accompanied by a sustained elevation in [14C]phosphorylcholine levels. In FSH-primed cells, TNF alpha inhibited P450-AROM activity in a dose-dependent manner, an effect that was also observed in cells treated with bacterial sphingomyelinase (SMase 0.003-0.3 U/ml) or increasing concentrations (0.1-10 microM) of N-acetylsphingosine (C2-cer) a membrane-permeable analogue of ceramide. These results support the notion that sphingomyelin degradation to a bioeffector molecule ceramide, may be an early event involved in TNF alpha-induced signal transduction in granulosa cells.
URI: http://hdl.handle.net/10553/53520
ISSN: 0013-7227
DOI: 10.1210/endo.136.5.7720683
Fuente: Endocrinology [ISSN 0013-7227], v. 136 (5), p. 2345-2348 (Mayo 1995)
Colección:Artículos
Vista completa

Citas SCOPUSTM   

72
actualizado el 17-nov-2024

Citas de WEB OF SCIENCETM
Citations

70
actualizado el 25-feb-2024

Visitas

91
actualizado el 11-may-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.